Suchergebnisse - "Patriarca, Andrea"

PubPharm (7)

1

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia : a randomized trial

enthalten in: Blood advances | 2024

von Mazzucconi, M. | Rodeghiero, F. | Avvisati, G. | +37

2

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera : 5-year drug survival and efficacy outcomes

enthalten in: Annals of hematology | 2024

von Barbui, T. | Carobbio, A. | De Stefano, V. | +38

3

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV) : a multicentre, randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Broome, C. | McDonald, V. | Miyakawa, Y. | +83

4

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia : Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Oliva, E. | Riva, M. | Niscola, P. | +39

CommentIn: J Clin Oncol. 2023 Oct 1;41(28):4465-4468. - PMID 37428990

5

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia : Results of a Randomized Phase III Trial Within the EMSCO Network

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Itzykson, R. | Santini, V. | Thepot, S. | +30

6

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera

enthalten in: NEJM evidence | 2023

von Barbui, T. | Vannucchi, A. | De Stefano, V. | +35

7

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study) : a multicentre, randomised phase 2 trial

enthalten in: The Lancet. Haematology | 2021

von Barbui, T. | Vannucchi, A. | De Stefano, V. | +34

ErratumIn: Lancet Haematol. 2021 Mar;8(3):e170. - PMID 33515489

1
[1]